Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival
作者
John Crown,Daniil Stroyakovskii,Denise A. Yardley,Chiun‐Sheng Huang,Peter A. Fasching,Amit Bardia,S. Chia,Seock‐Ah Im,Miguel Martín,B. Xu,Carlos H. Barrios,Michael Untch,R Moroose,Sara A. Hurvitz,Gabriel N. Hortobágyi,Dennis J. Slamon,F. Visco,Gonzalo Spera,Juan Pablo Zarate,Doug N. Halligan
出处
期刊:ESMO open [Elsevier BV] 日期:2025-10-17卷期号:10 (11): 105858-105858被引量:7